WallStreetZenWallStreetZen

NYSE: DGX
Quest Diagnostics Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for DGX

Based on 11 analysts offering 12 month price targets for Quest Diagnostics Inc.
Min Forecast
$129.00+5.44%
Avg Forecast
$147.36+20.44%
Max Forecast
$170.00+38.95%

Should I buy or sell DGX stock?

Based on 12 analysts offering ratings for Quest Diagnostics Inc.
Hold
Strong Buy
2 analysts 16.67%
Buy
0 analysts 0%
Hold
10 analysts 83.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DGX stock forecasts and price targets.

DGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Top 4%
97
HoldAssumes$142.00+16.06%2022-08-22
Mizuho
Top 24%
77
Strong BuyMaintains$160.00+30.77%2022-07-22
Credit Suisse
Top 5%
96
HoldMaintains$143.00+16.88%2022-07-22
Anonymous
Morgan Stanley
HoldMaintains$142.00+16.06%2022-05-03
Wells Fargo
Bottom 21%
21
HoldMaintains$150.00+22.60%2022-04-25
Bank of America
Top 6%
95
Strong BuyMaintains$163.00+33.22%2022-04-22
Citigroup
Top 5%
96
HoldDowngradesN/AN/A2022-04-04
UBS
Bottom 27%
27
HoldDowngrades$139.00+13.61%2022-02-23
Morgan Stanley
Top 2%
99
HoldMaintains$145.00+18.51%2022-02-14
Wells Fargo
Top 7%
94
HoldMaintains$145.00+18.51%2022-02-04

1 of 2

Forecast return on equity

Is DGX forecast to generate an efficient return?
Company
16.04%
Industry
536.32%
Market
108.79%
DGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DGX forecast to generate an efficient return on assets?
Company
7.73%
Industry
11.48%
DGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DGX earnings per share forecast

What is DGX's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$9.69-21.22%
Avg 2 year Forecast
$8.33-32.28%
Avg 3 year Forecast
$8.82-28.29%
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

DGX revenue forecast

What is DGX's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$9.6B-9%
Avg 2 year Forecast
$9.1B-14.32%
Avg 3 year Forecast
$9.1B-13.56%
DGX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DGX earnings growth forecast

How is DGX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-15.3%
Industry
14.78%
Market
18.27%
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
DGX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

DGX revenue growth forecast

How is DGX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-6.5%
Industry
3.74%
Market
8.22%
DGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DGX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DGX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
DGX$122.35$147.36+20.44%Hold
PHG$15.86N/AN/ABuy
PKI$122.31$168.89+38.08%Hold
ICLR$190.84$270.70+41.85%Buy
WAT$275.50$343.33+24.62%Hold
View Top Diagnostic & Research Stocks

Quest Diagnostics Stock Forecast FAQ

Is Quest Diagnostics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 12 Wall Street analysts covering (NYSE: DGX) stock is to Hold DGX stock.

Out of 12 analysts, 2 (16.67%) are recommending DGX as a Strong Buy, 0 (0%) are recommending DGX as a Buy, 10 (83.33%) are recommending DGX as a Hold, 0 (0%) are recommending DGX as a Sell, and 0 (0%) are recommending DGX as a Strong Sell.

If you're new to stock investing, here's how to buy Quest Diagnostics stock.

What is DGX's earnings growth forecast for 2022-2024?

(NYSE: DGX) Quest Diagnostics's forecast annual earnings growth rate of -15.3% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 14.78%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.27%.

Quest Diagnostics's earnings in 2022 is $1,484,000,000.On average, 6 Wall Street analysts forecast DGX's earnings for 2022 to be $1,129,914,989, with the lowest DGX earnings forecast at $1,113,590,108, and the highest DGX earnings forecast at $1,138,077,429. On average, 7 Wall Street analysts forecast DGX's earnings for 2023 to be $971,330,429, with the lowest DGX earnings forecast at $881,543,583, and the highest DGX earnings forecast at $1,020,305,073.

In 2024, DGX is forecast to generate $1,028,467,513 in earnings, with the lowest earnings forecast at $949,175,233 and the highest earnings forecast at $1,076,276,094.

What is DGX's revenue growth forecast for 2022-2024?

(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of -6.5% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.22%.

Quest Diagnostics's revenue in 2022 is $10,582,000,000.On average, 6 Wall Street analysts forecast DGX's revenue for 2022 to be $1,122,932,020,944, with the lowest DGX revenue forecast at $1,097,177,771,820, and the highest DGX revenue forecast at $1,133,548,790,800. On average, 6 Wall Street analysts forecast DGX's revenue for 2023 to be $1,057,224,257,669, with the lowest DGX revenue forecast at $1,042,448,607,731, and the highest DGX revenue forecast at $1,101,229,840,536.

In 2024, DGX is forecast to generate $1,066,615,611,981 in revenue, with the lowest revenue forecast at $1,046,687,363,124 and the highest revenue forecast at $1,085,039,056,614.

What is DGX's forecast return on assets (ROA) for 2022-2024?

(NYSE: DGX) forecast ROA is 7.73%, which is lower than the forecast US Diagnostics & Research industry average of 11.48%.

What is DGX's Price Target?

According to 11 Wall Street analysts that have issued a 1 year DGX price target, the average DGX price target is $147.36, with the highest DGX stock price forecast at $170.00 and the lowest DGX stock price forecast at $129.00.

On average, Wall Street analysts predict that Quest Diagnostics's share price could reach $147.36 by Aug 22, 2023. The average Quest Diagnostics stock price prediction forecasts a potential upside of 20.44% from the current DGX share price of $122.35.

What is DGX's Earnings Per Share (EPS) forecast for 2022-2024?

(NYSE: DGX) Quest Diagnostics's current Earnings Per Share (EPS) is $12.30. On average, analysts forecast that DGX's EPS will be $9.69 for 2022, with the lowest EPS forecast at $9.55, and the highest EPS forecast at $9.76. On average, analysts forecast that DGX's EPS will be $8.33 for 2023, with the lowest EPS forecast at $7.56, and the highest EPS forecast at $8.75. In 2024, DGX's EPS is forecast to hit $8.82 (min: $8.14, max: $9.23).

What is DGX's forecast return on equity (ROE) for 2022-2024?

(NYSE: DGX) forecast ROE is 16.04%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.